Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
mAb 1D2
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
VS-5584
Potential treatment - theoretical effect Experimental Antiviral Nov/05/2020
P5A-2G9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Tegobuvir
Potential treatment - theoretical effect Experimental Antiviral Aug/24/2020
A-2H4
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021
Rigosertib
Potential treatment - pre-clinical evidence Experimental Other treatment Jun/27/2020
Bemcentinib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
E-3B1
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021
[3-(5-methoxy-2-hydroxy benzylidene amino)-2(5-methoxy-2-hydroxyphenyl)-2,3-dihydro quinazoline-4(1H)-one]
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
Remikiren
Potential treatment - theoretical effect Experimental Antiviral Dec/24/2020
SATPdb18674
Potential treatment - theoretical effect Experimental Antiviral Oct/21/2020
P5A-1B8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Sb23
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/04/2020
1-[1-(6-Chloroquinolin-4-yl)piperidin-4-yl]piperidin-3-ol
Potential treatment - theoretical effect Experimental Antiviral Jan/20/2021
A-1H4
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021
Edotecarin
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
CoV2-12
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
RBD-NVP
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/20/2020
Quisinostat
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Quinoline,1,2,3,4-tetrahydro-1-[(2-phenylcyclopropyl)sulfonyl]-trans-(8CI)
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020